Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease (vol 101, pg 801, 2019)

被引：30
|
作者：
Tabrizi, Sarah J.
Ghosh, Rhia
Leavitt, Blair R.
机构：
来源：
NEURON | 2019年 / 102卷 / 04期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
D O I：
10.1016/j.neuron.2019.05.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：899 / 899
页数：1
相关论文
共 50 条
  • [1] Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
    Tabrizi, Sarah J.
    Ghosh, Rhia
    Leavitt, Blair R.
    NEURON, 2019, 101 (05) : 801 - 819
  • [2] Huntingtin-lowering strategies for Huntington's disease
    Barker, Roger A.
    Fujimaki, Motoki
    Rogers, Priya
    Rubinsztein, David C.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1125 - 1132
  • [3] Targeting Huntingtin Expression in Patients with Huntington's Disease (vol 380, pg 2307, 2019)
    Tabrizi, S. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14): : 1398 - 1398
  • [4] SUMO modification of Huntingtin and Huntington's disease pathology
    Steffan, JS
    Agrawal, N
    Pallos, J
    Rockabrand, E
    Trotman, LC
    Slepko, N
    Illes, K
    Lukacsovich, T
    Zhu, YZ
    Cattaneo, E
    Pandolfi, PP
    Thompson, LM
    Marsh, JL
    SCIENCE, 2004, 304 (5667) : 100 - 104
  • [5] Huntingtin-Lowering Strategies in Huntington's Disease: Antisense Oligonucleotides, Small RNAs, and Gene Editing
    Aronin, Neil
    DiFiglia, Marian
    MOVEMENT DISORDERS, 2014, 29 (11) : 1455 - 1461
  • [6] Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies
    M. Borrell-Pagès
    D. Zala
    S. Humbert
    F. Saudou
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 2642 - 2660
  • [7] Huntington's disease:: from huntingtin function and dysfunction to therapeutic strategies
    Borrell-Pages, M.
    Zala, D.
    Humbert, S.
    Saudou, F.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (22) : 2642 - 2660
  • [8] Platelet abnormalities in Huntington's disease (vol 90, pg 272, 2019)
    Denis, H. L.
    Lamontagne-Proulx, J.
    St-Amour, I
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (07): : E6 - E6
  • [9] Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice
    Caron, Nicholas S.
    Banos, Raul
    Aly, Amirah E.
    Xie, Yuanyun
    Ko, Seunghyun
    Potluri, Nalini
    Anderson, Christine
    Black, Hailey Findlay
    Anderson, Lisa M.
    Gordon, Benjamin
    Southwell, Amber L.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2022, 166
  • [10] Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression
    Bahat, Anat
    Itzhaki, Elad
    Weiss, Benjamin
    Tolmasov, Michael
    Tsoory, Michael
    Kuperman, Yael
    Brandis, Alexander
    Shurrush, Khriesto A.
    Dikstein, Rivka
    EMBO MOLECULAR MEDICINE, 2024, 16 (03) : 523 - 546
12345